Virax Biolabs Group (VRAX) Stock Chart & Stock Price History $1.02 +0.03 (+2.50%) As of 10:40 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Virax Biolabs Group Stock Price Performance The Virax Biolabs Group (VRAX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 21.25%, with a year-to-date return of -55.11%. In the past month, the stock has decreased 0.98%, reflecting recent market activity. As of the latest close, Virax Biolabs Group traded at $1.02 with a market cap of $3.28 million and volume of 46,454 shares. Receive VRAX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virax Biolabs Group and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-6.48%1 Month Performance-0.98%3 Month Performance-45.99%Year-To-Date Performance-55.11%1 Year Performance+21.25% VRAX Stock Chart for Friday, May, 23, 2025 VRAX Chart by TradingView Virax Biolabs Group Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/22/2025$1.04$1.02-2.40%$1.03$1.0046,454 shs$3.28 million05/21/2025$1.10$1.04-5.02%$1.19$1.02112,390 shs$3.36 million05/20/2025$1.07$1.10+2.24%$1.11$1.0543,767 shs$3.54 million05/19/2025$1.08$1.07-0.83%$1.10$1.0631,133 shs$3.46 million05/16/2025$1.06$1.08+1.89%$1.08$0.97106,733 shs$3.49 million05/15/2025$1.09$1.06-2.30%$1.11$1.0677,248 shs$3.43 million05/14/2025$1.06$1.09+2.84%$1.20$1.06278,097 shs$3.51 million05/13/2025$1.07$1.06-1.40%$1.10$1.0568,084 shs$3.41 million05/12/2025$1.05$1.07+1.90%$1.08$1.0320,339 shs$3.46 million05/09/2025$1.06$1.05-0.94%$1.07$1.0416,889 shs$3.40 million Get the Latest News and Ratings for VRAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virax Biolabs Group and its competitors with MarketBeat's FREE daily newsletter. 05/08/2025$1.01$1.06+4.95%$1.08$1.0172,338 shs$3.43 million05/07/2025$1.01$1.01$1.04$1.0015,955 shs$3.27 million05/06/2025$1.02$1.01-0.49%$1.07$0.997,728 shs$3.27 million05/05/2025$1.02$1.02$1.04$0.9924,117 shs$3.28 million05/02/2025$0.98$1.02+3.57%$1.04$0.9833,243 shs$3.28 million05/01/2025$0.98$0.98-0.02%$1.08$0.98366,381 shs$3.17 million04/30/2025$1.04$0.98-5.75%$1.05$0.9862,749 shs$3.17 million04/29/2025$1.11$1.04-6.31%$1.08$1.0328,557 shs$3.36 million04/28/2025$1.05$1.11+5.71%$1.13$1.0667,966 shs$3.59 million04/25/2025$1.09$1.05-3.67%$1.07$1.0427,307 shs$3.40 million04/24/2025$1.02$1.09+6.86%$1.09$1.0148,524 shs$3.52 million04/23/2025$0.96$1.02+6.34%$1.04$0.9648,889 shs$3.30 million04/22/2025$0.91$0.96+5.05%$0.98$0.9133,715 shs$3.10 million Related Companies MEI Pharma Stock Chart ProPhase Labs Stock Chart Gelteq Stock Chart 23andMe Stock Chart Relmada Therapeutics Stock Chart Trinity Biotech Stock Chart Synlogic Stock Chart Eterna Therapeutics Stock Chart Marker Therapeutics Stock Chart Calidi Biotherapeutics Stock Chart Receive VRAX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virax Biolabs Group and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VRAX) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virax Biolabs Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Virax Biolabs Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VRAX Stock Free VRAX Stock Alerts